Stepan Co logo

Stepan Co

SCL

NYSEBasic MaterialsChemicals - Specialty

Regular session

$62.31

−$1.32 · -2.07%

Aug 24, 3:07 PM ET

SCL company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

55

Fair Value

Momentum

49

Neutral

Sentiment

51

Mixed

Risk resilience

67

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients; emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins used in coating applications; specialty polyols, such as CASE and powdered polyester resins; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
US
CEO
Luis E. Rojo
Listed since
Feb 21, 1973
Employees
2,328

Market position

Day range

Current $62.31

52-week range

Current $62.31

Open
$63.86
Previous close
$63.63
Volume
50.63K
0.35× average
Average volume
146.24K
Average daily volume
Market cap
1.42B USD
Beta
0.94
Market reference 1
50-day average
$59.1608
+5.32% above average
200-day average
$52.8041
+18.00% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.64B USD
EV / EBITDA
7.74×
Earnings yield
4.33%
Free cash flow yield
2.34%

Profitability & efficiency

Return on equity
3.77%
Return on assets
1.99%
Return on invested capital
2.73%

Financial health

Current ratio
1.29×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends18%12%6%0%Gross margin, FY2021: 16.87%Gross margin, FY2022: 15.40%Gross margin, FY2023: 11.94%Gross margin, FY2024: 12.49%Gross margin, FY2025: 11.57%Operating margin, FY2021: 7.28%Operating margin, FY2022: 7.48%Operating margin, FY2023: 2.52%Operating margin, FY2024: 3.23%Operating margin, FY2025: 2.98%Net margin, FY2021: 5.87%Net margin, FY2022: 5.31%Net margin, FY2023: 1.73%Net margin, FY2024: 2.31%Net margin, FY2025: 2.01%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 16.87%. Gross margin FY2022 15.40%. Gross margin FY2023 11.94%. Gross margin FY2024 12.49%. Gross margin FY2025 11.57%. Operating margin FY2021 7.28%. Operating margin FY2022 7.48%. Operating margin FY2023 2.52%. Operating margin FY2024 3.23%. Operating margin FY2025 2.98%. Net margin FY2021 5.87%. Net margin FY2022 5.31%. Net margin FY2023 1.73%. Net margin FY2024 2.31%. Net margin FY2025 2.01%.

Income trends

Revenue

2.33B USD+6.96%

Operating income

69.38M USD-1.56%

Net income

46.9M USD-6.90%
Income trends across reported periods3.05B USD1.95B USD860.12M USD−233.1M USDRevenue, FY2021: 2.35B USDRevenue, FY2022: 2.77B USDRevenue, FY2023: 2.33B USDRevenue, FY2024: 2.18B USDRevenue, FY2025: 2.33B USDOperating income, FY2021: 170.78M USDOperating income, FY2022: 207.34M USDOperating income, FY2023: 58.61M USDOperating income, FY2024: 70.48M USDOperating income, FY2025: 69.38M USDNet income, FY2021: 137.8M USDNet income, FY2022: 147.15M USDNet income, FY2023: 40.2M USDNet income, FY2024: 50.37M USDNet income, FY2025: 46.9M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.35B USD. Revenue FY2022 2.77B USD. Revenue FY2023 2.33B USD. Revenue FY2024 2.18B USD. Revenue FY2025 2.33B USD. Operating income FY2021 170.78M USD. Operating income FY2022 207.34M USD. Operating income FY2023 58.61M USD. Operating income FY2024 70.48M USD. Operating income FY2025 69.38M USD. Net income FY2021 137.8M USD. Net income FY2022 147.15M USD. Net income FY2023 40.2M USD. Net income FY2024 50.37M USD. Net income FY2025 46.9M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.33B USD2.18B USD2.33B USD2.77B USD2.35B USD
Cost of goods sold2.06B USD1.91B USD2.05B USD2.35B USD1.95B USD
Gross profit269.89M USD272.21M USD277.6M USD427.07M USD395.81M USD
Research and development59.28M USD55.67M USD59.04M USD66.63M USD62.69M USD
Selling, general, and administrative139.56M USD143.91M USD141.57M USD161.21M USD152.09M USD
Operating expenses200.51M USD201.73M USD218.99M USD219.73M USD225.03M USD
Interest income4.11M USD5.28M USD3.84M USD1.08M USD1.26M USD
Interest expense26.23M USD19.47M USD15.95M USD10.89M USD7.01M USD
Depreciation and amortization126.04M USD112.2M USD105.34M USD94.65M USD90.88M USD
Operating income69.38M USD70.48M USD58.61M USD207.34M USD170.78M USD
Net income46.9M USD50.37M USD40.2M USD147.15M USD137.8M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$85.00

36.41% upside
Past 12 months12-month forecastHigh $85.00Average $85.00Low $85.00

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$1.55

2025 complete year+24.0% since 2021

2026 partial: $0.79

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 1, 2026

$0.395

Quarterly

Record Sep 1, 2026 · Payment Sep 15, 2026

Dividend

Ex-dividend Jun 1, 2026

$0.395

Quarterly

Record Jun 1, 2026 · Payment Jun 15, 2026

Dividend

Ex-dividend Mar 2, 2026

$0.395

Quarterly

Record Mar 2, 2026 · Payment Mar 13, 2026

Dividend

Ex-dividend Nov 28, 2025

$0.395

Quarterly

Record Nov 28, 2025 · Payment Dec 15, 2025

Dividend

Ex-dividend Aug 29, 2025

$0.385

Quarterly

Record Aug 29, 2025 · Payment Sep 15, 2025

Dividend

Ex-dividend May 30, 2025

$0.385

Quarterly

Record May 30, 2025 · Payment Jun 13, 2025

SCL peers

ETFs holding SCL

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research SCL

research.disclaimer